Fetal Growth Retardation
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
Three mitochondrial genes, MT-ND5, MT-ND6, and MT-ATP6 were found negatively associated with IUGR, while one glycolysis-regulatory gene, PDK1 was positively associated with IUGR. mtDNA abundance and OS were positively associated with IUGR.
|
30251570 |
2020 |
Multiple Carboxylase Deficiency
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
In this report, we describe a newly-identified association of biochemical features of multiple carboxylase deficiency in individuals harboring mitochondrial DNA (mtDNA) mutations in MT-ATP6 and in whom organic acidemias and multiple carboxylase deficiencies were excluded.
|
29307858 |
2019 |
Childhood Acute Myeloid Leukemia
|
0.010 |
Biomarker
|
disease |
BEFREE |
This study was conducted to assess clinical significance of expression of mitochondrial-encoded genes, namely ND3, SDHB, Cytochrome b, Cytochrome C, and ATP6, in pediatric AML.
|
31119613 |
2019 |
Holocarboxylase Synthetase Deficiency
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
In this report, we describe a newly-identified association of biochemical features of multiple carboxylase deficiency in individuals harboring mitochondrial DNA (mtDNA) mutations in MT-ATP6 and in whom organic acidemias and multiple carboxylase deficiencies were excluded.
|
29307858 |
2019 |
High altitude pulmonary edema
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
The frequency of A10398G of MT-ND3, A8701G of MT-ATP6 and C14766T of MT-CYB genes were significantly higher in HAPE susceptibles. mtDNA copy number also plays a significant synergistic role in HAPE susceptibility.
|
31358833 |
2019 |
Kearns-Sayre syndrome
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Five of them harbored mtDNA deletions associated with Kearns-Sayre syndrome (KSS), one had a mitochondrial point mutation at the mtDNA ATPase6 gene, and one had a POLG mutation.
|
29974349 |
2018 |
Kidney Diseases
|
0.010 |
GeneticVariation
|
group |
BEFREE |
We previously identified a mutation in the mitochondrial MT-ATP6 gene (m.8969G>A) in a 14-year-old Chinese female who developed an isolated nephropathy followed by brain and muscle problems.
|
29778688 |
2018 |
Childhood Acute Lymphoblastic Leukemia
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Missense or nonsense mtDNA mutations were detected in the genes encoding subunits of OXPHOS complexes, as follows: MT-ND1, MT-ND2, MT-ND4L and MT-ND6 of complex I; MT-CO3 of complex IV; and MT-ATP6 and MT-ATP8 of complex V. We discovered mtDNA mutations in childhood ALL supporting the hypothesis that non-neutral variants in mtDNA affecting the OXPHOS function may be related to leukemic clones.
|
28708239 |
2018 |
Ophthalmoplegia
|
0.010 |
GeneticVariation
|
phenotype |
BEFREE |
Noninvasive genetic screening is recommended for mtDNA mutations in MT-NDs and MT-ATP6 genes in patients with ophthalmoplegia, muscle weakness, ataxia, and respiratory disorder.
|
30425197 |
2018 |
Osteoporosis
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
For example, the gene ATP6 V1G1, which has been implicated in osteoporosis, correlated with metabolites that are dysregulated by inhaled corticoid steroids (ICS), providing insight into the mechanisms underlying bone density loss in asthma patients taking ICS.
|
30335973 |
2018 |
Respiration Disorders
|
0.010 |
GeneticVariation
|
group |
BEFREE |
Noninvasive genetic screening is recommended for mtDNA mutations in MT-NDs and MT-ATP6 genes in patients with ophthalmoplegia, muscle weakness, ataxia, and respiratory disorder.
|
30425197 |
2018 |
Respiratory Tract Diseases
|
0.010 |
GeneticVariation
|
group |
BEFREE |
Noninvasive genetic screening is recommended for mtDNA mutations in MT-NDs and MT-ATP6 genes in patients with ophthalmoplegia, muscle weakness, ataxia, and respiratory disorder.
|
30425197 |
2018 |
Essential Hypertension
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
The mtDNA variations were mainly distributed in regions of ATP6 binding sites, and the site of highest mutation frequency was m. 8414C > T. Three changes in single bases (C8414T in ATP8, A8701G in ATP6 and G8584A in ATP6) were significantly different in the MIEH patients and the controls (P < 0.001).
|
30326913 |
2018 |
POLG mutation
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Five of them harbored mtDNA deletions associated with Kearns-Sayre syndrome (KSS), one had a mitochondrial point mutation at the mtDNA ATPase6 gene, and one had a POLG mutation.
|
29974349 |
2018 |
Amyotrophic Lateral Sclerosis
|
0.010 |
Biomarker
|
disease |
BEFREE |
Comprehensive ranking indicated RPS17 with MT-ATP6 as the best ICGs for qPCR in PBMCs of control and ALS subjects, and RPS17 with 18RNA or MT-ATP6 in LCLs from ALS.
|
28328930 |
2017 |
Metabolic Syndrome X
|
0.010 |
Biomarker
|
disease |
BEFREE |
But in the hepatocytes and skeletal muscle cells, the mitochondrial number decreased; 2.The mt-DNA encoded protein cytochrome b increased significantly in heart but decreased in liver and the ATPase6 increased in liver but decreased in heart of the MS rats; 3.
|
28957804 |
2017 |
RHYNS syndrome
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Mitochondrial (mt) DNA-associated NARP (neurogenic muscle weakness, ataxia, and retinitis pigmentosa) syndrome is due to mutation in the MT-ATP6 gene.
|
29054413 |
2017 |
Mitochondrial cardiomyopathy
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
The second patient with isolated mitochondrial cardiomyopathy presented the m.8605C>T (p.27P>S) mutation in the MT-ATP6 gene.
|
28104394 |
2017 |
Intellectual Disability
|
0.010 |
GeneticVariation
|
group |
BEFREE |
We describe a novel frameshift mutation in the mitochondrial ATP6 gene in a 4-year-old girl associated with ataxia, microcephaly, developmental delay and intellectual disability.
|
28412374 |
2017 |
IGA Glomerulonephritis
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Identification of G8969>A in mitochondrial ATP6 gene that severely compromises ATP synthase function in a patient with IgA nephropathy.
|
27812026 |
2016 |
Primary hypogonadism
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
We suggest that the m.8561C>G mutation in MT-ATP6/8 is pathogenic, leads biochemically to impaired assembly and decreased ATP production of complex V, and results clinically in a phenotype with the core features of cerebellar ataxia, peripheral neuropathy, diabetes mellitus, and hypergonadotropic hypogonadism.
|
27502083 |
2016 |
Prostate Cancer, Hereditary, 7
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
We investigated if Mexican-Mestizo men presenting this type of cancer, exhibited somatic mutations of ATP6 and/or ND3.Body mass index (BMI) was determined; the degree of prostate cancer aggressiveness was demarcated by the Gleason score.
|
27187822 |
2016 |
Trichohepatoenteric Syndrome
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Pathogenic mutations in MT-ATP6 are associated with the Leigh syndrome, the syndrome of neuropathy, ataxia, and retinitis pigmentosa (NARP), as well as with non-classical phenotypes, while MT-ATP8 is less frequently mutated in patients with mitochondrial disease.
|
27502083 |
2016 |
Overweight or obesity
|
0.010 |
GeneticVariation
|
phenotype |
BEFREE |
Genetic variants in ATP6 and ND3 mitochondrial genes are not associated with aggressive prostate cancer in Mexican-Mestizo men with overweight or obesity.
|
27187822 |
2016 |
Adenocarcinoma
|
0.010 |
GeneticVariation
|
group |
BEFREE |
Overall, we screened 121 adenomas and seven adenocarcinomas and their corresponding germinal controls, for mitochondrial genes with a crucial role in oxidative phosphorylation and translation (MT-CO1, MT-CO2, MT-CO3, MT-TD, MT-TS1, MT-ATP6) as well as a hypervariable sequence (HV-II) within the control region displacement loop (D-loop), a marker of hypermutability and clonal expansion.
|
26138249 |
2015 |